Article | September 16, 2015

Accelerate Treatments To Market With Less Risk: Partner With A CRO That Uses The Medidata Clinical Cloud

Source: Medidata Solutions
RISK

Historically, scientific innovation alone in the absence of any significant pricing pressures was sufficient to maintain return on investment (ROI) and deliver on unmet medical needs. Now, the game has changed: scientific innovation must go hand in hand with operational innovation to meet the needs of patients and investors. Medidata firmly believes that innovative drug development is not a luxury, but a market and societal necessity. Some of the new market leaders will be those sponsors that partner with clinical research organizations (CROs) that are able to achieve the efficiencies required to cost-effectively support sponsors’ scientific and operational delivery needs.